Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2

Area of Science:

• Molecular Biology
• Virology
• Biochemistry

Background:

• Eukaryotic translation initiation typically requires the specialized eukaryotic initiation factor 2 (eIF2) complex.
• This complex delivers the initiator tRNA to the ribosome for protein synthesis.
• Hepatitis C virus (HCV) presents a unique case in translation initiation.

Purpose of the Study:

• To investigate the translation initiation mechanism of the Hepatitis C virus (HCV) internal ribosome entry site (IRES).
• To determine if HCV IRES can initiate translation independently of the conventional eukaryotic factors.
• To elucidate the specific factors involved in the HCV IRES-mediated translation.

Main Methods:

• Analysis of HCV IRES-driven translation in vitro and in cell-based systems.
• Investigating the role of various initiation factors, including eIF2, eIF5, eIF5B, and eIF3.
• Studying the impact of cellular stress conditions on translation initiation pathways.

Main Results:

• The HCV IRES directs translation initiation without requiring eIF2 and its associated GTPase-activating protein, eIF5.
• HCV IRES utilizes a bacterial-like translation initiation pathway.
• This pathway exclusively requires eIF5B and eIF3, bypassing the standard eukaryotic machinery.

Conclusions:

• HCV IRES employs an alternative, eIF2-independent translation initiation mechanism.
• This mechanism resembles bacterial translation initiation, utilizing eIF5B and eIF3.
• The switch to this pathway is observed when eIF2 is inactivated, particularly under cellular stress conditions.